Азбука финансовой грамотности. ВСЕ серии Волноваха
Other News by This Author
Other News Volnovakha
Other News Ukraine
Держаудитори розповіли про результати моніторингу закупівель у серпні.
Держаудитори повідомляють, що постійно аналізуючи закупівлі, що проводяться на prozorro.gov.ua, у серпні місяці, виявили підстави для проведення 38 моніторингів публічних закупівель, охоплено контролем закупівлі загальною вартістю понад 192 млн гривень.
За результатами проведених фахівцями Північно-східного офісу Держаудитслужби моніторингів по 22 процедурам закупівель, попереджено незаконні витрати бюджетних коштів на загальну суму понад 52 млн гривень.
Найпопулярніші порушення, що допускають замовники – це порушення законодавства в частині розгляду та не відхилення замовником тендерної пропозиції, невідповідність тендерної документації вимогам законодавства та порушення встановлених законом термінів оприлюднення інформації на веб-порталі prozorro.gov.ua.
На виконання наданих Офісом приписів, замовниками здійснено відміну результатів 15 торгів на суму понад 45 млн грн та розірвано 7 укладених договорів на суму понад 6 млн гривень.
За допущені порушення вимог законодавства у сфері закупівель, у серпні місяці до судових органів направлено один протокол про адміністративне правопорушення, для подальшого притягнення особи до адміністративної відповідальності.
Other world news
DNA Sequencing Market Shows Highest Growth Potential
Major players profiled in the report are Perkin Elmer, Roche Holdings AG, Siemens AG, Illumina, Agilent Technologies Inc., Genia Corporation, Oxford Nanopore technologies, Koninklijke Philips N.V., Pacific Biosciences, Johnson & Johnson, Deep Genomics, Inc., Life Technologies, Illumina, Eppendorf, Tecan, and Thermo Scientific, Hamilton Thorne Biosciences, General Electric Company, Siemens Healthineers GmbH, Myriad Genetics, Bayer Corporation, Beckman Coulter and others.
Get Sample Report at https://www.marketresearchfuture.com/sample_request/5774
DNA is composed of repeated units of four bases adenine, guanine, cytosine, and thymine. DNA sequencing involves determining the precise nucleotides order in a DNA molecule.
The drivers of the DNA Sequencing Market Size are adoption of precision medicine, growth in complimentary industries and applications such as biotechnology, forensic biology, virology and molecular biology. Projects such as human genome project and the growing adoption of genetics for livestock and agriculture research is providing new avenues for the market.
Next generation sequencing finds extensive use in cancer research due to its advantages over traditional genomic analysis methods such as ability to measures real time nucleotides addition to a DNA molecule low cost, high accuracy, speed, and precision, low sample requirements. Development of the DNA field-effect transistor (DNAFET) is opening up another vista for the market. DNAFET uses field-effect exploiting the partial charges of DNA molecules which functions as a biosensor. DNAFET measures charge distribution on complementary DNA strands, and converts them into current transport through the semiconductor transducer.
The restraints include high cost of development and maintenance, nascent state of the technology, concerns about data safety, ethical considerations and others.
The global DNA Sequencing Market Analysis is segmented on the basis of devices, process, technology, applications, technique, end users and regions so as to gain an accurate assessment of the market.
Based on the types, the market has been segmented as instruments, consumables and others. The instruments is sub segmented into sequencers, bioreactors, and others. The consumables is sub segmented into reagents and chemicals, laboratory wares, and other.
Based on the process the market has been segmented into sample preparation, sequencing, data analysis, and others.
Based on the technology, the market has been segmented as chain terminator DNA sequencing, next generation DNA sequencing, and others.
Based on the application, the market has been segmented as diagnostics, drug discovery, precision medicine, livestock research, agriculture research, and others.
Based on the technique, the market has been segmented as ion semiconductor sequencing, pyro-sequencing, synthesis sequencing (SBS), ligation sequencing, single molecule real time sequencing (SMRT), chain termination sequencing, Nano pore sequencing and others.
Based on the end users, the market has been segmented as hospitals and clinics, forensics, genomics and livestock’s, academics and research institutes, pharmaceutical and biotechnology industry, and others.
Based on the regions, the market has been segmented as North America, Europe, Asia Pacific Middle East and Africa and rest of the world.
North America followed by Europe accounts for the largest market share owing to developed innovation ecology, large buying power, faster adoption of technology, and presence of major players. The compulsory screening for new burns and presence of orphan diseases drugs reimbursement also charges the market. Genetic modified foods industry is also providing the market with a major impetus.
Get Full Report at https://www.marketresearchfuture.com/reports/dna-sequencing-market-5774
Europe is dominated by U.K., Germany, and France is the second largest market. The market is anticipated to shift to Asia Pacific which is estimated to be the fastest growing region led by Japan, China and India. The Middle East and Africa market are expected to deliver moderate growth led by the Gulf nations such as Saudi Arabia and UAE.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Phone: +1 646 845 9312
Email: [email protected]
Swab Market Size, Top Key Players, Latest Trends, Regional Insights and Global Industry 2027
Swabs refer to medicated absorbent pads or materials which impart medicinal properties. They are used during surgeries and other medical procedures, for pre-injection or as wound cleaners. Swabs generally contain antiseptics such as chlorhexidine, cetrimide or iodine or disinfectants such as alcohol. As per the analysis of Market Research Future (MRFR), the global swab market is expected to showcase moderate growth over the forecast period of 2017-2023.
Swabs are considered as an indispensable tool in diagnostic procedures where they are used for collection of samples. The surge in the number of forensic and genetic sampling examinations has induced high demand within the global swab market. Additionally, there has been a sharp increase in the number of road accidents in recent years. The occurrence of major wounds and injuries has escalated the need for swabs which boosts the growth of the global swab market. Furthermore, with the rise in disposable income on a global scale, consumers are more inclined towards personal care. Other factors contributing to the growth of the global swab market include a surge in the number of patient care centers, increasing affordability among consumers, and high healthcare expenditure purveyed by elevating levels of income.
Maternal Health Market Pegged for Robust Expansion Forecast to 2027 | Market Research Future
The maternal health market is growing at a steady pace. The complications are seen to be more prevalent in the elderly pregnant ladies. The complications are of extremely high risk and cab occur due to changing lifestyle and trends. The habits of smoking and drinking is considered to be one of the major issues behind such complications. In developed nations and urban developing countries, a number of women smoking population is high. In developing countries, women who are between the age of 15-19 are reportedly found dead because of various complications during pregnancy and child birth.
The global maternal health market was analyzed by Market Research Future (MRFR) and it was projected that a healthy CAGR of 7% will be attained by the market over the forecast period of 2017 to 2023. The valuation of the maternal health market was further stated to surpass its previous valuation with the revenue pool getting wider.